elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q30846827-4FC34929-D442-4CAB-9D09-223155FDAA08
Q30846827-4FC34929-D442-4CAB-9D09-223155FDAA08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30846827-4FC34929-D442-4CAB-9D09-223155FDAA08
Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.
P2860
Q30846827-4FC34929-D442-4CAB-9D09-223155FDAA08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30846827-4FC34929-D442-4CAB-9D09-223155FDAA08
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2c7a69487b46bbdbb2fd8e24fd5550bb25adaf34
P2860
Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: a multicenter prospective Phase II trial.